|
|
|
|
|
Teisinis statusas
Patento galiojimo terminas pasibaigęs
| (51) | INT.CL. | A61K 31/4985 | (2006.01) |
| A61P 1/08 | (2006.01) | ||
| A61P 25/00 | (2006.01) | ||
| A61P 25/04 | (2006.01) | ||
| A61P 25/06 | (2006.01) | ||
| A61P 25/08 | (2006.01) | ||
| A61P 25/20 | (2006.01) | ||
| A61P 25/22 | (2006.01) | ||
| A61P 25/24 | (2006.01) | ||
| A61P 25/28 | (2006.01) | ||
| A61P 25/30 | (2006.01) | ||
| A61P 29/00 | (2006.01) | ||
| A61P 37/08 | (2006.01) | ||
| A61P 43/00 | (2006.01) | ||
| C07D 487/04 | (2006.01) |
| (11) | Patento numeris | 1472256 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 03702621.8 |
| Europos patento paraiškos padavimo data | 2003-02-10 | |
| (97) | Europos patento paraiškos paskelbimo data | 2004-11-03 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2005-11-02 |
| (46) | Apibrėžties vertimo paskelbimo data | 2006-04-25 |
| (86) | Numeris | PCT/EP2003/001308 |
| Data | 2003-02-10 |
| (87) | Numeris | WO 2003/066635 |
| Data | 2003-08-14 |
| (30) | Numeris | Data | Šalis |
| 0203020 | 2002-02-08 | GB |
| (72) |
ALVARO, Giuseppe GlaxoSmithKline SpA, IT
DI FABIO, Romano GlaxoSmithKline SpA, IT
TRANQUILLINI, Maria Elvira GlaxoSmithKline SpA, IT
SPADA, Simone GlaxoSmithKline SpA, IT
|
| (73) |
NeRRe Therapeutics Limited,
Stevenage Bioscience Catalyst, Office F25 Incubator Building, Gunnels Wood Road, Stevenage Herts, SG1 2FX,
GB
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Piperidino dariniai |
| PIPERIDINE DERIVATIVES |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2022-02-09 | 347.00 EUR |